Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Inotuzumab Ozogamicin Is an Effective Salvage Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia with High-Risk Molecular Features, Including TP53 Loss

Xiaochuan Yang, Amber C. King, PharmD, BCOP, Charlene C. Kabel, PharmD, Christopher J. Forlenza, MD, Jae H. Park, MD, Mark B. Geyer, MD

Blood (2019) 134 (Supplement_1): 3888.

https://doi.org/10.1182/blood-2019-125165

Published: 2019

Journal Articles

The First Case of Primary Cardiac Lymphoma, Diffuse Large B-Cell Type, Successfully Treated with EPOCH-R

Sherise Chantell Rogers, MD MPH, Owen A. O'Connor, MD PhD, Glen Granati, MD, Kavitha Yaddanapudi, MD

Blood (2016) 128 (22): 5418.

https://doi.org/10.1182/blood.V128.22.5418.5418

Published: 2016

Journal Articles

Transient Protein C Deficiency in an Infant with Factor V Leiden Heterozygous Mutation: a Rare Subgroup of Neonatal Purpura Fulminans

Sagar Pathak, DO, Natalie L. Kamberos, DO

Blood (2016) 128 (22): 4985.

https://doi.org/10.1182/blood.V128.22.4985.4985

Published: 2016

Journal Articles

Primary Cardiac Burrkit Lymphoma: Characteristics, Clinical Presentation and Outcome

Mohamed Jumayli, MD, Emily Chen, MD, Hossein Sadrzadeh, MD

Blood (2015) 126 (23): 5048.

https://doi.org/10.1182/blood.V126.23.5048.5048

Published: 2015

Journal Articles

A Rare Case of Kimura's Disease with Superior Vena Cava Syndrome and Biatrial Masses

Jie Sun, Rui Li, He Huang, MD, PhD, Wanzhuo Xie, Xiaoli Zhu, Huan Qian, Zhen Wang, Shan Fu

Blood (2010) 116 (21): 5068.

https://doi.org/10.1182/blood.V116.21.5068.5068

Published: 2010

Journal Articles

ICL670 Removes Cardiac Iron in a Gerbil Model of Iron Overload.

John C. Wood, MD, PhD, Maya Otto-Duessel, MS, Ignacio Gonzales, MD, Michelle Aguilar, BS, Hanspeter Nick, PhD, Hiro Shimada, MD, Rex Moats, PhD

Blood (2005) 106 (11): 2695.

https://doi.org/10.1182/blood.V106.11.2695.2695

Published: 2005

NARROW

Inotuzumab Ozogamicin Is an Effective Salvage Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia with High-Risk Molecular Features, Including TP53 Loss

The First Case of Primary Cardiac Lymphoma, Diffuse Large B-Cell Type, Successfully Treated with EPOCH-R

Transient Protein C Deficiency in an Infant with Factor V Leiden Heterozygous Mutation: a Rare Subgroup of Neonatal Purpura Fulminans

Primary Cardiac Burrkit Lymphoma: Characteristics, Clinical Presentation and Outcome

A Rare Case of Kimura's Disease with Superior Vena Cava Syndrome and Biatrial Masses

ICL670 Removes Cardiac Iron in a Gerbil Model of Iron Overload.

Email alerts

ASH Publications

American Society of Hematology

Inotuzumab Ozogamicin Is an Effective Salvage Therapy in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia with High-Risk Molecular Features, Including TP53 Loss

The First Case of Primary Cardiac Lymphoma, Diffuse Large B-Cell Type, Successfully Treated with EPOCH-R

Transient Protein C Deficiency in an Infant with Factor V Leiden Heterozygous Mutation: a Rare Subgroup of Neonatal Purpura Fulminans

Primary Cardiac Burrkit Lymphoma: Characteristics, Clinical Presentation and Outcome

A Rare Case of Kimura's Disease with Superior Vena Cava Syndrome and Biatrial Masses

ICL670 Removes Cardiac Iron in a Gerbil Model of Iron Overload.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only